Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 7/20 | 0.34 |
| ▸ | ATR | Q13535 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 3/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31458624 | 0.79 | MAPK1 (0.33) | IRAK4MAPK1ABL1PIK3CGCREBBP | |
| SCHEMBL25226135 | 0.71 | CD274 (0.39) | IRAK4MAPK1 | |
| SCHEMBL31458619 | 0.67 | PIM1 (0.37) | MAPK1 | |
| SCHEMBL31458620 | 0.67 | PIM1 (0.37) | MAPK1 | |
| SCHEMBL32684321 | 0.67 | CDK4 (0.38) | — | |
| SCHEMBL25221517 | 0.63 | JAK2 (0.36) | IRAK4MAPK1ATR | |
| SCHEMBL31458578 | 0.62 | CDK2 (0.44) | MAPK1 | |
| SCHEMBL25223794 | 0.60 | AXL (0.39) | IRAK4MAPK1 | |
| SCHEMBL25197104 | 0.60 | AXL (0.39) | IRAK4MAPK1 | |
| SCHEMBL30347690 | 0.60 | AXL (0.39) | IRAK4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096061-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-05-08 | — | — | WO | disclosed |